B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

The next-gen immunotherapies market is evolving with biotech advances, rising cancer cases, new therapies, funding, and ...

Rusty Konkol's metastatic melanoma, the most dangerous form of skin cancer, is being treated at Froedtert with a newly approved cancer drug.

Jenny Ahlstrom, 57, was diagnosed with multiple myeloma, a form of blood cancer, in 2010. Following her diagnosis, she was ...

The biopharmaceutical sector is underpinned by a unique ecosystem that combines public funding for basic research, university ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

As community oncology evolves to deliver chimeric antigen receptor (CAR) T and bispecific therapies closer to home, support is needed to ensure patient access and precision medicine capabilities, says ...

The administration's cuts at the National Institutes of Health will obliterate billions in economic gains, America's ...

POLB 001 has been granted FDA orphan drug designation as a preventative therapy for cytokine release syndrome caused by ...

The administration's cuts at the National Institutes of Health will obliterate billions in economic gains, America's ...

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...